Pal et al., Cancer Res 2001
(Breast Neoplasms) :
The present study indicates that p53 can also inhibit the hypoxic induction of Src kinase activity and thereby may prevent VPF/VEGF transcription
Ping-Yuan et al., Apoptosis 2006
(Reoviridae Infections) :
Inhibition of Src by over-expression of C-terminal Src kinase (Csk) or treatment with Src family tyrosine kinase inhibitor SU-6656 diminished the ARV S1133 induced p53 expression, activation, and apoptosis
Mukhopadhyay et al., Cancer Res 1995
(Neovascularization, Pathologic) :
Moreover, v-Src , in the presence of wt-p53 , was unable to activate transcription of the VEGF promoter